Mobile Edition
Print
Get the Mag
Weekly UpdatesCephalon (Frazer, PA) received FDA approval of Fentora (fentanyl) for the management of breakthrough pain in opiod-tolerant patients with cancer. Fentora will be available in dosage strengths of 100, 200, 400, 600, and 800 [micro]g.
|
More Resources
|
|||
Persistent cancer pain.(FDA Focus: A monthly review of FDA activity, including issuances of approvals, labeling changes, and gui
COPYRIGHT 2006 Medicom International,
Inc. Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company. NOTE: All illustrations and photos have been removed from this article. |
|||
FEED